Journal Article

Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant

  • Krause K
  • Metz M
  • Zuberbier T
  • et al.
Journal der Deutschen Dermatologischen Gesellschaft (2009)
DOI: 10.1111/j.1610-0387.2009.07215.x
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The bradykinin B2 receptor antagonist icatibant has recently become available for treating hereditary angioedema. Our observations demonstrate icatibant to be effective and safe for the treatment of both, abdominal and cutaneous attacks in a practice setting beyond clinical studies. © Blackwell Verlag GmbH, Berlin.

Cite

CITATION STYLE

APA

Krause, K., Metz, M., Zuberbier, T., Maurer, M., & Magerl, M. (2009). Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Journal Der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/j.1610-0387.2009.07215.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free